INTERNATIONAL PATENT: I2O THERAPEUTICS, INC. FILES APPLICATION FOR "COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG AND USES THEREOF"

GENEVA, March 4 -- I2O THERAPEUTICS, INC. (610 Main StreetCambridge, Massachusetts 02139) filed a patent application (PCT/US2025/042839) for "COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF" on Aug 20, 2025. With publication no. WO/2026/044024, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROWN, Tyler (610 Main StreetCambridge, Massach...